Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae

Mahmoud Saad Abdel-Halim,Amira M. El-Ganiny,Basem Mansour,Galal Yahya,Hemat K. Abd El Latif,Momen Askoura

DOI: https://doi.org/10.1186/s12866-024-03214-7

IF: 4.465

2024-02-29

BMC Microbiology

Abstract:Carbapenems represent the first line treatment of serious infections caused by drug-resistant Klebsiella pneumoniae . Carbapenem-resistant K. pneumoniae (CRKP) is one of the urgent threats to human health worldwide. The current study aims to evaluate the carbapenemase inhibitory potential of coumarin and to test its ability to restore meropenem activity against CRKP. Disk diffusion method was used to test the antimicrobial susceptibility of K. pneumoniae clinical isolates to various antibiotics. Carbapenemase genes (NDM-1, VIM-2, and OXA-9) were detected using PCR. The effect of sub-MIC of coumarin on CRKP isolates was performed using combined disk assay, enzyme inhibition assay, and checkerboard assay. In addition, qRT-PCR was used to estimate the coumarin effect on expression of carbapenemase genes. Molecular docking was used to confirm the interaction between coumarin and binding sites within three carbapenemases.

microbiology

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: **Research on Carbapenemase Inhibitors and Their Therapeutic Potential for Carbapenem - Resistant Klebsiella pneumoniae (CRKP)** Specifically, the paper aims to evaluate the potential of coumarin as a carbapenemase inhibitor and test its ability to restore the activity of meropenem (a commonly used carbapenem - based antibiotic) against carbapenem - resistant Klebsiella pneumoniae (CRKP). The research was carried out by the following methods: 1. **Antibiotic Sensitivity Testing**: The disk diffusion method was used to test the sensitivity of clinically isolated Klebsiella pneumoniae to multiple antibiotics. 2. **Carbapenemase Gene Detection**: PCR was used to detect the presence of carbapenemase genes such as NDM - 1, VIM - 2 and OXA - 9 in Klebsiella pneumoniae. 3. **Determination of the Minimum Inhibitory Concentration (MIC) of Coumarin**: The micro - dilution method was used to determine the minimum inhibitory concentrations of coumarin and meropenem against Klebsiella pneumoniae. 4. **Effect of Coumarin on the Metabolic Activity of CRKP**: The Alamar Blue assay was used to evaluate the effect of sub - MIC concentrations of coumarin on the metabolic activity of Klebsiella pneumoniae. 5. **Combination Disk Test**: The synergistic effect when coumarin was used in combination with meropenem was evaluated. 6. **Carbapenemase Inhibition Test**: The inhibitory effect of coumarin on the activity of carbapenemase in crude - extracted periplasmic proteins was determined. 7. **qRT - PCR Analysis**: The effect of coumarin on the expression of carbapenemase genes was evaluated. 8. **Molecular Docking Study**: Molecular docking was used to simulate the binding mode of coumarin and carbapenemase to verify its binding ability. The research results show that coumarin can significantly inhibit the activity of carbapenemase, reduce its gene expression, and show a synergistic effect when used in combination with meropenem, thereby restoring the antibacterial activity of meropenem against CRKP. These findings provide a new potential solution for overcoming carbapenem - based antibiotic resistance.

Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae

Study on the antibiotic resistance mechanism and the molecular epidemiology of Klebsiella pneumoniae with reduced susceptibility to Carbapenems

Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in an imipenem-resistant Serratia marcescens isolate

Efficacy of synergistic antibiotic combinations against KPC-2 carbapenemase producing Klebsiella pneumoniae strains

Identification of Plasmid-Mediated Carbapenem-Hydrolyzing Β-Lactamase KPC-2 in Enterobacteriaceae

Identification and phylogenetic analysis of carbapenemase genes from clinical strains of Klebsiella pneumoniae

Direct Klebsiella pneumoniae Carbapenem Resistance and Carbapenemases Genotype Prediction by Al-MOF/TiO2@Au Cubic Heterostructures-Assisted Intact Bacterial Cells Metabolic Analysis

Genomic Characterization of KPC-31 and OXA-181 Klebsiella pneumoniae Resistant to New Generation of β-Lactam/β-Lactamase Inhibitor Combinations

Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods

Characterization, Antibiotic Susceptibility, and Clonal Analysis of Carbapenem-Resistant Klebsiella pneumoniae From Different Clinical Cases

Clinical Characteristics and Molecular Insights of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Patients in Intensive Care Units

Phenotypic and molecular characterization of multi-drug resistant Klebsiella spp. isolates recovered from clinical settings

Comparative study of phenotypic-based detection assays for carbapenemases in Acinetobacter baumannii

Phenotypic and Genotypic Characterization of Pan-Drug-Resistant Klebsiella pneumoniae Isolated in Qatar

Investigating the relationship between carbapenemase production and biofilm formation in Klebsiella pneumoniae clinical isolates

Characterization of Corosolic Acid as a KPC-2 Inhibitor That Increases the Susceptibility of KPC-2-Positive Bacteria to Carbapenems

Coumarin (2H-1-Benzopyran-2-one) act against planktonic and biofilm forms of Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa

Characterization of Porin Expression in Klebsiella Pneumoniae Carbapenemase (Kpc)-Producing K. Pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems.

Investigation on the mechanisms of carbapenem resistance among the non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae

Phenotypic detection of Carbapenamase among Klebsiella pneumoniae isolated from clinical samples using modified Hodged test

Development and Validation of a Novel Multiplex Real-Time PCR Assay for Rapid Detection of Carbapenemase Genes in Carbapenem-Resistant Enterobacterales Isolates and Clinical Samples